Lupin to buy 21 generic brands from Japan’s Shionogi for $150m

Lupin to buy 21 generic brands from Japan’s Shionogi for $150m

An employee of Lupin Limited works at a reception at their headquarters in Mumbai November 22, 2013. REUTERS/Danish Siddiqui/Files

Lupin Ltd, India’s third largest drug maker, on Tuesday said it has agreed to buy a portfolio of 21 generic brands from Osaka-based Shionogi & Co. Ltd for $150 million, to strengthen its presence in the world’s second largest pharmaceutical market.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter